Risk base Technical transfer in pharmaceutical manufacturing
Technical Transfer of processes to an alternative site occurs at some stage
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Technical Transfer of processes to an alternative site occurs at some stage
important for the successful commercialization. Scaling manufacturing to meet commercial requirements Unlike the manufacturing processes of small-molecule drugs that can be chemically synthesized and easily replicated…
Abstract Introduction: Benign Prostatic Hyperplasia (BPH) is a slowly progressing process of
intensification of pharmaceutical protein production processes can be achieved by the integration of unit operations and application of recurring sequences of all biochemical process steps. Within optimization…
A Nutraceutical product may be defined as a substance, which has physiological
medication from an underlying plan to its entrance into the market is an extreme process which can take around 8-12 years and cost around $1.7 billion. The thought ... business part, and so on. Once an objective for…
Botanical) preparations as approved drugs (pharmaceuticals). Such preparations have historically been the basis for many (most) traditional medicines but have not usually been developed clinically in such ... provide…
revealed the development of unique strategies from plants for responding to abiotic stress, with one of the most interesting being through priming for improved defense responses. The process of priming ... patented…
pitfalls listed above. Trying to think through on how to improve the process at-risk patient prediction along with the ability to validate and replicate the modeling outcomes, this presentation ... Delivery. Journal of…
technologies that have been widely used in other industries, however are new to pharmaceutical manufacturing. Therefore, the use of these techniques in drug delivery and tissue engineering applications, including…
The success to use subunit viral vaccine to prevent a particular viral
automatic process control. Recent Publications: 1. EMEA (2009) (Doc. Ref. EMEA/CHMP/CVMP/QWP/17760/2009 Rev 1) - Guideline on the use of Near Infrared Spectroscopy by the Pharmaceutical Industry ... data requirements…
New technologies and processes are being developed for existing and new drug
In order to control drug substance (DS) properties one has to select
Math-physical medicine approach (MPM) utilizes mathematics, physics, engineering models, and computer
Ever since the introduction and pharmaceutical development of antibiotics (~1940’s), public health and well-being has improved significantly. (Hajipour MJ, 2012). However, due to drug misuse, mismanagement and poor…
We studied the role of the additives trehalose and Poly Vinyl Pyrrolidone
Clinical applications of oral protein therapy for the treatment of various chronic
Preservatives have long been used in the formulation of liquid and semisolid
proteins represent the fastest growing market of the pharmaceutical industry and there is a tremendous rush by many companies worldwide to develop Biosimilar versions of innovator products. The type ... biosimilar…
Biologics that target autoimmune responses and inflammatory injury pathways have a marked
The global biosimilars market estimated worth of $2.3 billion in 2015, and
The global biosimilars market is USD 5.95 billion and expected to reach
presentation is focused in drug development process and how the drug formulation places an important role in medicinal product success. We present how the drug formulation can impact ... present a new technology…
drugs and genes is an exciting area of research at the interface of pharmaceutical sciences and biomedical engineering. Drug carriers are sought to encapsulate a drug cargo, protect it from ... examples of magnetically-…
For authors and organisers
Find the right journal for your paper and submit your manuscript.